Information  X 
Enter a valid email address

Deepverge PLC (DVRG)

  Print   

Wednesday 15 September, 2021

Deepverge PLC

India Centre of Excellence for Modern Water AMBC

RNS Number : 7823L
Deepverge PLC
15 September 2021
 

15 th September 2021   

DeepVerge plc

DeepVerge and Ion Exchange announce India Centre of Excellence for Modern Water All Membrane Brine Concentration ("AMBC")

Successful trials meet requirements for three AMBC installations worth US$ 1 Million (£750k). 

DeepVerge plc (AIM:DVRG) and Ion Exchange (India) Limited (BSE: 500214) announce the establishment of a technology partnership "Centre of Excellence for India and the Middle East" using Modern Water's All Membrane Brine Concentration ("AMBC") technology, and Ion Exchange's proven capabilities in design, engineering, construction, operation and maintenance of membrane systems that will culminate into three projects for the installation of AMBC worth US$ 1 million (£750k). 

 

Background:

Ion Exchange completed construction of an AMBC pilot plant earlier this year with initial trials in June 2021 with subsequent trials to be initiated in September 2021, compiling daily logs and detailed documentation on its performance. Modern Water Membrane division supported the project with AMBC technology, design expertise, training, development and preparation of training materials. After successful conclusion of the pilot plant trial, the Ion/DVRG collaboration are intending to proceed with the AMBC technology platform for two projects in India and one in the Middle East.

Ajay Popat, CEO of Ion, commented: 

"The AMBC solutions we have selected for these projects provides quantifiable cost reductions making zero liquid discharge affordable as well as providing environmental benefits in terms of massively reduced pollution.  Having successfully commissioned 25+ complete Zero Liquid Discharge, we realise the need for brine concentration has never been greater with increased focus on wastewater minimalisation, water recycling and Zero Liquid Discharge.. 

We are pleased to announce this deepening of our partnership in development of a joint AMBC cooperation model to strengthen our technical and sales capability in the wastewater sector in addition to Modern Water's further expertise in toxicity testing and environmental monitoring."

Gerard Brandon, CEO of DeepVerge, commented: 

"We are delighted to extend our partnership with Ion Exchange securing a stronger footprint for Modern Water Membrane and Monitoring across India and the Middle East. The three installations and a state of the art reference centre with all Modern Water equipment available under one roof represents a major commitment to the AMBC technology platform and adds real-time monitoring of wastewater, highlighting the demand for these recycling innovations to counter the global water crisis in this rapidly growing market."

The three projects for the supply of Modern Water's AMBC technology into manufacturing plants are expected to close in Q4 2021. The first project is for Ion Exchange's existing resin plant, located in Ankleshwar, Gujarat, India. The second is for a new resin plant currently being designed for building in H1 2022 in Roha, Maharashtra, India. The third is for a large oil & gas customer of Ion Exchange, located in Oman.  

 

Ajay Popat, CEO of Ion Exchange, will be a speaker at the pre-COP 26 Reuters IMPACT conference ( https://reutersevents.com/events/impact/ ) at which DeepVerge is a sponsor, on the topic "What is our water trying to tell us? A global perspective" with input from thought leaders from India, China, the UK and the City of Los Angeles.

 

DeepVerge plc

Gerard J. Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

Mo PR Advisory 

Mo Noonan

+44 (0) 7876 444 977

 

About DeepVerge plc (www.deepverge.com):

The Company is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulated technology.  From scientifically proving skincare product claims on skin microbiome for top 10 global cosmetic company clients,  to real-time, remote detection and identification of dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

About Ion Exchange (India) Limited (www.ionindia.com): 

Ion Exchange, India, provides environment solutions throughout the Indian Sub-Continent and across the Middle East, covering water treatment, liquid waste treatment and recycling, air pollution control, solid and hazardous waste management, and the renewable energy from waste. Specialists in water and wastewater treatment for over five decades, Ion Exchange revenues exceed US$200 million and manages nearly 1,500 staff. By delivering quantifiable benefits for customers, they demonstrate efficient water management as a critical value-added investment .

 

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUSAKRABUKAAR

a d v e r t i s e m e n t